B Braun Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?
B BRAUN MEDICAL INC has eleven approved drugs.
There are two US patents protecting B BRAUN MEDICAL INC drugs.
There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-nine supplementary protection certificates in fifteen countries.
Summary for B Braun Medical Inc
| International Patents: | 27 |
| US Patents: | 2 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 11 |
| Drug Master File Entries: | 21 |
Drugs and US Patents for B Braun Medical Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical Inc | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 209705-003 | Feb 27, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun Medical Inc | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 209705-002 | Feb 27, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun Medical Inc | MAGNESIUM SULFATE | magnesium sulfate | INJECTABLE;INJECTION | 207967-003 | Apr 26, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun Medical Inc | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 209705-001 | Feb 27, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun Medical Inc | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 208474-001 | Aug 3, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for B Braun Medical Inc Drugs
Supplementary Protection Certificates for B Braun Medical Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1499331 | C300615 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NATRIUMSULFAAT, MAGNESIUMSULFAAT EN KALIUMSULFAAT; NAT. REGISTRATION NO/DATE: RVG 110863 20130417; FIRST REGISTRATION: BE 434323 20130220 |
| 2957286 | 1990003-4 | Sweden | ⤷ Sign Up | PRODUCT NAME: PATRIOMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179 20170721 |
| 2957286 | 2018/046 | Ireland | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| 2957286 | CR 2018 00043 | Denmark | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721 |
| 0933372 | SPC/GB08/018 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
